|
KDELR2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.59569999991227E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.71080999999962E-05 |
| Normal-vs-Stage2 |
2.176000E-03 |
| Normal-vs-Stage3 |
1.3103000018333E-08 |
| Normal-vs-Stage4 |
6.71809999852613E-08 |
| Stage1-vs-Stage2 |
8.493800E-01 |
| Stage1-vs-Stage3 |
2.883900E-02 |
| Stage1-vs-Stage4 |
9.580500E-03 |
| Stage2-vs-Stage3 |
9.130000E-02 |
| Stage2-vs-Stage4 |
3.268100E-02 |
| Stage3-vs-Stage4 |
3.380000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.514800001574E-08 |
| Normal-vs-AfricanAmerican |
1.060300E-02 |
| Normal-vs-Asian |
8.30860000000655E-05 |
| Caucasian-vs-AfricanAmerican |
5.616200E-01 |
| Caucasian-vs-Asian |
3.908400E-01 |
| AfricanAmerican-vs-Asian |
9.459200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.22389999996009E-06 |
| Normal-vs-Female |
3.11049999979218E-07 |
| Male-vs-Female |
7.421400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.75490000004142E-06 |
| Normal-vs-Age(41-60Yrs) |
1.32870000002505E-06 |
| Normal-vs-Age(61-80Yrs) |
2.5593000000379E-06 |
| Normal-vs-Age(81-100Yrs) |
2.862400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.454200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.145620E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.190000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.939400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.570000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.828610E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.344500E-03 |
| Classical-VS-Follicular |
8.550200E-01 |
| Classical-VS-Other |
1.412050E-01 |
| Classical-VS-Normal |
1.25559999997193E-06 |
| Tall-VS-Follicular |
5.222000E-02 |
| Tall-VS-Other |
6.326200E-01 |
| Tall-VS-Normal |
5.373599998304E-08 |
| Follicular-VS-Other |
2.833600E-01 |
| Follicular-VS-Normal |
4.809600E-04 |
| Other-VS-Normal |
2.779500E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.55389999999733E-05 |
| Normal-vs-N1 |
8.03320000519747E-08 |
| N0-vs-N1 |
3.816500E-02 |
|
|
